107 related articles for article (PubMed ID: 32028107)
1. Computational approach to target USP28 for regulating Myc.
Chakravorty D; Ghosh A; Saha S
Comput Biol Chem; 2020 Apr; 85():107208. PubMed ID: 32028107
[TBL] [Abstract][Full Text] [Related]
2. USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.
Wang H; Meng Q; Ding Y; Xiong M; Zhu M; Yang Y; Su H; Gu L; Xu Y; Shi L; Zhou H; Zhang N
FEBS J; 2021 Feb; 288(4):1325-1342. PubMed ID: 32578360
[TBL] [Abstract][Full Text] [Related]
3. Fbw7 and Usp28 regulate myc protein stability in response to DNA damage.
Popov N; Herold S; Llamazares M; Schülein C; Eilers M
Cell Cycle; 2007 Oct; 6(19):2327-31. PubMed ID: 17873522
[TBL] [Abstract][Full Text] [Related]
4. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.
Wrigley JD; Gavory G; Simpson I; Preston M; Plant H; Bradley J; Goeppert AU; Rozycka E; Davies G; Walsh J; Valentine A; McClelland K; Odrzywol KE; Renshaw J; Boros J; Tart J; Leach L; Nowak T; Ward RA; Harrison T; Andrews DM
ACS Chem Biol; 2017 Dec; 12(12):3113-3125. PubMed ID: 29131570
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-specific protease USP28 is required for MYC stability.
Popov N; Wanzel M; Madiredjo M; Zhang D; Beijersbergen R; Bernards R; Moll R; Elledge SJ; Eilers M
Nat Cell Biol; 2007 Jul; 9(7):765-74. PubMed ID: 17558397
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of USP28 enhances the radiosensitivity of esophageal cancer cells via the c-Myc/hypoxia-inducible factor-1 alpha pathway.
Weili Z; Zhikun L; Jianmin W; Qingbao T
J Cell Biochem; 2019 Jan; 120(1):201-212. PubMed ID: 30206969
[TBL] [Abstract][Full Text] [Related]
7. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.
Diefenbacher ME; Popov N; Blake SM; Schülein-Völk C; Nye E; Spencer-Dene B; Jaenicke LA; Eilers M; Behrens A
J Clin Invest; 2014 Aug; 124(8):3407-18. PubMed ID: 24960159
[TBL] [Abstract][Full Text] [Related]
9. E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc.
Zhong L; Zhang Y; Li M; Song Y; Liu D; Yang X; Yang D; Qu H; Lai L; Wang Q; Chen Z
Aging (Albany NY); 2020 Dec; 12(23):24394-24423. PubMed ID: 33260160
[TBL] [Abstract][Full Text] [Related]
10. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease.
Ren Y; Zhu X; Fu K; Zhang H; Zhao W; Lin Y; Fang Q; Wang J; Chen Y; Guo D
Biochem Pharmacol; 2023 Jan; 207():115355. PubMed ID: 36442624
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
13. Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer.
Hidayat M; Mitsuishi Y; Takahashi F; Tajima K; Yae T; Miyahara K; Hayakawa D; Winardi W; Ihara H; Koinuma Y; Wirawan A; Nurwidya F; Kato M; Kobayashi I; Sasaki S; Takamochi K; Hayashi T; Suehara Y; Moriyama M; Moriyama H; Habu S; Takahashi K
Bosn J Basic Med Sci; 2019 Nov; 19(4):355-367. PubMed ID: 31202256
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-specific protease 28 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity by regulating MYC expression.
Wang Z; Song Q; Xue J; Zhao Y; Qin S
Exp Biol Med (Maywood); 2016 Feb; 241(3):255-64. PubMed ID: 26209720
[TBL] [Abstract][Full Text] [Related]
15. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.
Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D
Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242
[TBL] [Abstract][Full Text] [Related]
16. Lysine-52 stabilizes the MYC oncoprotein through an SCF
De Melo J; Kim SS; Lourenco C; Penn LZ
Oncogene; 2017 Dec; 36(49):6815-6822. PubMed ID: 28806398
[TBL] [Abstract][Full Text] [Related]
17. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.
Sun XX; He X; Yin L; Komada M; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3734-9. PubMed ID: 25775507
[TBL] [Abstract][Full Text] [Related]
18. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
[TBL] [Abstract][Full Text] [Related]
19. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc.
Zhang J; Ren P; Xu D; Liu X; Liu Z; Zhang C; Li Y; Wang L; Du X; Xing B
Cancer Lett; 2019 Jan; 440-441():106-115. PubMed ID: 30343112
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma.
Sun X; Cai M; Wu L; Zhen X; Chen Y; Peng J; Han S; Zhang P
Cancer Sci; 2022 Oct; 113(10):3463-3475. PubMed ID: 35880246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
